Cite

HARVARD Citation

    Devi Daimary, U. et al. (2022). Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases. Journal of biochemical and molecular toxicology. 36 (2), p. n/a. [Online]. 
  
Back to record